These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Low molecular weight chitosan is an efficient inhibitor of ribonucleases. Yakovlev GI; Mitkevich VA; Struminskaya NK; Varlamov VP; Makarov AA Biochem Biophys Res Commun; 2007 Jun; 357(3):584-8. PubMed ID: 17442276 [TBL] [Abstract][Full Text] [Related]
3. Ribonucleases in tumor growth. Shlyakhovenko VA Exp Oncol; 2009 Sep; 31(3):127-33. PubMed ID: 19783970 [TBL] [Abstract][Full Text] [Related]
4. The RNAse-RNAse inhibitor system in the liver of the frog Rana esculenta: subcellular distribution and differential binding of inhibitor with multiple RNAses. Malicka-Błaszkiewicz M; Kubicz A Acta Physiol Pol; 1981; 32(3):317-26. PubMed ID: 6975551 [TBL] [Abstract][Full Text] [Related]
5. Ribonucleases: from prototypes to therapeutic targets? Loverix S; Steyaert J Curr Med Chem; 2003 May; 10(9):779-85. PubMed ID: 12678781 [TBL] [Abstract][Full Text] [Related]
7. [Isolation of intracellular inhibitors of bacterial RNAses on a column with immobilized Bacillus intermedius RNAse]. Bannikova GE; Varlamov VP Prikl Biokhim Mikrobiol; 1994; 30(3):379-83. PubMed ID: 8047536 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic ribonucleases and chimeras in cancer therapy. Youle RJ; Newton D; Wu YN; Gadina M; Rybak SM Crit Rev Ther Drug Carrier Syst; 1993; 10(1):1-28. PubMed ID: 8472310 [TBL] [Abstract][Full Text] [Related]
9. Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs. Gotte G; Menegazzi M Front Immunol; 2019; 10():2626. PubMed ID: 31849926 [TBL] [Abstract][Full Text] [Related]
10. [Why ribonucleases cause death of cancer cells]. Il'inskaia ON; Makarov AA Mol Biol (Mosk); 2005; 39(1):3-13. PubMed ID: 15773542 [TBL] [Abstract][Full Text] [Related]
11. Ribonucleases of different origins with a wide spectrum of medicinal applications. Fang EF; Ng TB Biochim Biophys Acta; 2011 Jan; 1815(1):65-74. PubMed ID: 20843477 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of mammalian ribonucleases by endogenous adenosine dinucleotides. Kumar K; Jenkins JL; Jardine AM; Shapiro R Biochem Biophys Res Commun; 2003 Jan; 300(1):81-6. PubMed ID: 12480524 [TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors--turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases. Riester D; Hildmann C; Schwienhorst A Appl Microbiol Biotechnol; 2007 Jun; 75(3):499-514. PubMed ID: 17377788 [TBL] [Abstract][Full Text] [Related]
14. Natural and engineered ribonucleases as potential cancer therapeutics. Arnold U; Ulbrich-Hofmann R Biotechnol Lett; 2006 Oct; 28(20):1615-22. PubMed ID: 16902846 [TBL] [Abstract][Full Text] [Related]
16. Binase and other microbial RNases as potential anticancer agents. Makarov AA; Kolchinsky A; Ilinskaya ON Bioessays; 2008 Aug; 30(8):781-90. PubMed ID: 18623073 [TBL] [Abstract][Full Text] [Related]
17. Ribonucleases as antiviral agents. Ilinskaya ON; Mahmud RS Mol Biol; 2014; 48(5):615-623. PubMed ID: 32214473 [TBL] [Abstract][Full Text] [Related]
18. [A preliminary analysis on a group of low molecular weight RNases in wheat and related species]. Zhao H; Liu KF; Wang DW Yi Chuan Xue Bao; 2000; 27(5):423-7. PubMed ID: 10979188 [TBL] [Abstract][Full Text] [Related]